Instructions for Completing Form FDA 3500
The FDA has issued updated instructions for completing Form FDA 3500, providing guidance on how to document and submit adverse event reports.
Biologics manufacturers, healthcare professionals, and regulatory compliance teams responsible for reporting adverse events, product problems, or medical errors.
Accurate completion of Form FDA 3500 is critical for maintaining regulatory compliance and supporting the FDA's post-market surveillance efforts. While the source provides instructions rather than a new mandate, any revisions to reporting protocols suggest a focus on data quality and standardization in safety reporting. Improperly filed forms may lead to administrative delays or requests for additional information during safety signal evaluations.
Regulatory and pharmacovigilance teams should review these updated instructions to ensure internal SOPs for manual adverse event reporting remain aligned with current FDA data entry field requirements. Cross-reference internal reporting templates against Form 3500 updates to mitigate the risk of incomplete submissions.